Emergings In Brief, September 2013
This article was originally published in Start Up
Brief profiles of these recently formed companies: ColoWrap, Enteris BioPharma, HealthTell, and Novelogics Biotechnology.
You may also be interested in...
Pharma and biotech companies raised $4.6bn in the first quarter, exceeding the 2017 quarterly average by $1.4bn. But while the money invested soared, the number of companies funded sank. In public financings, MorphoSys commences US IPO and Mylan sells $1.5bn in notes.
In Vivo's editors pick January's most significant deals, including an alliance of players new to health care and Celgene's big buys. (Free article.)